Share Name Share Symbol Market Type Share ISIN Share Description
Silence Therapeutics Plc LSE:SLN London Ordinary Share GB00B9GTXM62 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +16.00p +6.67% 256.00p 252.00p 256.00p 256.00p 240.00p 240.00p 589,129 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -20.5 -26.2 - 200

Silence Therapeutics Share Discussion Threads

Showing 50301 to 50325 of 50825 messages
Chat Pages: Latest  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  Older
DateSubjectAuthorDiscuss
09/3/2018
10:43
Topped up this morning after checking the valuations over the pond for SLN's peers and the sharp rises over there. Presenting next week, too, which may generate some interest. Any NASDAQ listing should get an increased valuation for SLN. Bet Ali wishes he had held onto ARWR for a bit longer though!
callumross
08/3/2018
11:43
No it wouldn't but I suspect many of the companies in this space would rather disagree.
waterloo01
08/3/2018
11:19
Are you discounting the fact that they might hold fundamental IP that underlies all of the RNAi companies (not just ALNYLAM/MDCO),which could be the best new drug modality since monoclonals? Does the market cap sufficiently reflect this potential?
rnainvestor
07/3/2018
11:31
On reflection, while Nasdaq listing might be interesting, it will be at least 6 months off (it takes that amount of time) and any move by ALNY isn't likely till they get results in summer or nearer the case if they were to settle. However the rest of the business really hasn't moved on at all (except for all the extra people). They seem not much further forward, despite the spend on R&D than they were all those many years ago when AUT027 was the big hope. Once again they are too scatter gun in approach IMO. Only had a tiny holding but have decided to cash it in. Will keep an eye though on any movements. best of luck to the many old names here.
waterloo01
06/3/2018
08:32
I missed the Nasdaq reference at first glance. Interesting. I get the impression this is a management team with more than half an eye focused on the share price and the potential to support the price with the carefully managed release of information.
1gw
06/3/2018
07:20
Better cash than expected (due to Arrowhead sales) and looking at Nasdaq listing. Case not expected till end 2018. Might ALNY make a move?
waterloo01
02/3/2018
12:46
Summer I think, so not imminent.
waterloo01
02/3/2018
12:23
Any idea on the timescales for these ALNY approvals Waterloo?
callumross
02/3/2018
11:37
Bought back very small position. Less on results but more bounce from any ALNY approvals due. Would be milestone for RNAI.
waterloo01
02/3/2018
11:02
Remarkably stable. And there's been remarkably little (apparent) trading so far in the run-up to Tuesday's results. Here's hoping for some good news on Tuesday.
1gw
15/2/2018
03:53
How stable has that price been since mid Dec! Despite market volatility it's been up and down and around 190-200 mark pretty much all the way through. What does it mean? Probably not a lot, but it's been a calm sea for a while now and which way and when is the next storm going to pass through? Million dollar question as always!
ukeagle2aus
31/1/2018
15:16
Nice to see Robert Keith increasing his holding, albeit with spreadbets!
callumross
30/1/2018
00:54
Start of another climb, or just a little bounce on the bumpy road?
ukeagle2aus
03/1/2018
21:14
Arrowhead up around 25% today.
1gw
27/12/2017
16:24
Sold some at just under 195p to lock in a bit more profit for the year (and raise some cash).
1gw
11/12/2017
13:37
http://www.bbc.co.uk/news/health-42308341
callumross
05/12/2017
05:00
Hi Bare, apologies been away for a couple of weeks. Yes we are still here in Aus, in fact the day you posted was our tenth anniversary of being here. I am not surprised your eldest loves it here, its a great lifestyle, but to be fair you still need to work hard to benefit from it. Glad to see you also tucked away your holding in the bottom drawer until the end. Hoping that the activity recently will finally reward all of us long term holders and anyone else who has got in recently. ARWR sale was indeed an interesting trade 1gw? Who knows a bit of profit taking or a bit of gamesmanship?
ukeagle2aus
04/12/2017
08:30
Nice bit of profit-taking on the arwr stake. I wonder what that will do to the arwr share price today? And whether it's all part of the game to get some meaningful dialogue going with arwr?
1gw
29/11/2017
21:41
But back down again to close to $3.50 on huge volume today.
1gw
28/11/2017
16:05
Arrowhead back over $4.
1gw
24/11/2017
00:35
Hi Eagle....Just thought I'd look in...didnt know if you were still here. I rarely come on her now. Still have a few to keep until the end :-) Hows you...still in Auz?? My eldest went there 5 weeks ago for a year...Hes 18 and loving it!! :-)
barefoot1
21/11/2017
15:01
Try buying any shares via self trade , keeps sending order to dealer . Only allows purchase of 100 shares ........
partner
21/11/2017
06:37
Sure but shares are consolidating around the 200p level and plenty of news flow to come over the next 12 months. Plus free option big pharma takes us out
rogen83
20/11/2017
12:06
I thought the RNS was fairly good at pointing out that ALNYLAM are dragging their heels somewhat? SLN have defended the counter claim quick smart whilst ALNY & co haven't put out their defence of the original action taken by SLN. Market obviously doesn't agree yet?
ukeagle2aus
14/11/2017
19:06
95 pages of presentation from the capital markets day have made it to the website. Looks to be heavy on science and light on patents/litigation news, which I presume was the intent - try to reposition the company a bit in the mind of investors after all the news on strategic stakes and potential patent infringement. hTtp://www.silence-therapeutics.com/media/1721/silence-cmd-14-november-2017_download.pdf
1gw
Chat Pages: Latest  2021  2020  2019  2018  2017  2016  2015  2014  2013  2012  2011  2010  Older
Your Recent History
LSE
SLN
Silence Th..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20191020 20:22:34